Honeycomb-like Structured Film, a Novel Therapeutic Device, Suppresses Tumor Growth in an In Vivo Ovarian Cancer Model
Ovarian cancer cell dissemination can lead to the mortality of patients with advanced ovarian cancer. Complete surgery for no gross residual disease contributes to a more favorable prognosis than that of patients with residual disease. HCFs have highly regular porous structures and their 3D porous s...
Main Authors: | Tsuyoshi Ohta, Masaru Tanaka, Seitaro Taki, Hiroyuki Nakagawa, Satoru Nagase |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/1/237 |
Similar Items
-
Mechanism of Cell Death by Combined Treatment with an xCT Inhibitor and Paclitaxel: An Alternative Therapeutic Strategy for Patients with Ovarian Clear Cell Carcinoma
by: Urara Idei, et al.
Published: (2023-07-01) -
Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets
by: Yumin Qiu, et al.
Published: (2022-11-01) -
Potential Therapeutic Targets in Ovarian Cancer: Autophagy and Metabolism
by: Misung Park, et al.
Published: (2023-03-01) -
The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer
by: Ludivine Dion, et al.
Published: (2020-07-01) -
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
by: Wojciech Szymanowski, et al.
Published: (2023-11-01)